Produktsname: | Streptomycin |
CAS Registry Number: | 57-92-1 |
EINECS: | 200-355-3 |
Synonyme: | N,N'''-[(1S,2S,3S,4R,5S,6R)-4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)-alpha-D-mannopyranosyl]-3-C-formyl-beta-D-ribofuranosyl}oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine;Streptomycin (Oral);Streptomycin; Streptomycin (Inj.); |
Molecular Structure: | |
Molecular Formula: | C21H39N7O12 |
Molecular Weight: | 581.57 |
Dichte: | 1.98g/cm3 |
Boiling Point: | 948.2°Cat760mmHg |
Flash Point: | 527.3°C |
S-Sätze: | Poison by intravenous and subcutaneous routes. Moderately toxic by ingestion and intraperitoneal routes. An experimental teratogen. Human systemic effects by ingestion and intraperitoneal routes: change in vestibular functions, blood pressure decrease, eosinophilia, respiratory depression, and pulmonary changes. Human reproductive and teratogenic effects by unspecified routes: developmental abnormalities of the eye and ear and effects on newborn including postnatal measures or effects. Toxic to kidneys and central nervous system. Has been implicated in aplastic anemia. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx. |
Gefahrensymbole: | Damage to nerves and kidneys may result from ingestion. Use restricted by FDA. |